Ads
related to: Antibody and Antibodiesorigene.com has been visited by 10K+ users in the past month
Search results
ASCO: Early peek at Merus' bispecific cancer data lives up to investors' expectations
FierceBiotech· 5 days agoAnalysts have hailed Merus’ latest data drop in head and neck cancer as meeting investors’...
HI-Bio reports findings from Phase II trial in kidney transplant recipients
Clinical Trials Arena via Yahoo Finance· 2 days agoHuman Immunology Biosciences (HI-Bio) has reported positive outcomes from the Phase II clinical...
Why Is Sensei Biotherapeutics (SNSE) Stock Down 40% Today?
InvestorPlace· 5 days agoSensei Biotherapeutics (NASDAQ:SNSE) stock is falling on Friday after it failed to impress investors...
BioNTech pays $25M upfront to strengthen ADC bond with China's MediLink
FierceBiotech· 1 day agoAfter penning a couple of antibody-drug conjugate (ADC) deals in 2023, BioNTech has returned to MediLink Therapeutics to further pad out its portfolio. This time, BioNTech ...
Merck to acquire EyeBio in potential $3B deal
NJBIZ· 6 hours agoThe agreement will bring EyeBio into Merck’s umbrella as a subsidiary. The privately held ophthalmology-focused biotechnology company is developing a pipeline of clinical and preclinical candidates ...
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga· 2 hours agoSeltorexant is an investigational first-in-class selective antagonist of the human orexin-2 receptor...
Innovent to take IL-23 psoriasis drug to Chinese regulators after phase 3 win
FierceBiotech· 1 day agoThe anti-IL-23 monoclonal antibody, called picankibart, hit all primary and key secondary endpoints...
Understanding Viral Clearance During Anion-Exchange Chromatography
BioresearchOnline· 9 hours agoAnion-exchange chromatography is a commonly used method in the purification of biotherapeutics to remove viruses and impurities. To gain a better understanding of the mechanism of virus removal ...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 2 days agoSanofi is seeking approval for Sarclisa, a monoclonal antibody, in combination with bortezomib,...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoCTX-471, a novel anti-CD137 agonist antibody, demonstrated anti-tumor activity in the Company’s Phase 1 Dose Escalation and Dose Expansion, first-in-human monotherapy study ...
Ad
related to: Antibody and Antibodiesabcam.com has been visited by 10K+ users in the past month
